Page last updated: 2024-08-23

torsemide and Cardiac Failure

torsemide has been researched along with Cardiac Failure in 132 studies

Research

Studies (132)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.27)18.7374
1990's25 (18.94)18.2507
2000's44 (33.33)29.6817
2010's37 (28.03)24.3611
2020's23 (17.42)2.80

Authors

AuthorsStudies
Alonso-Galicia, M; Bailey, T; Brochu, RM; de Jesus, RK; Ding, FX; Ehrhart, J; Felix, JP; Garcia, ML; Gu, X; Ha, S; Hampton, C; Hernandez, M; Jiang, J; Kaczorowski, GJ; Owens, K; Pai, LY; Parmee, ER; Pasternak, A; Pio, B; Priest, BT; Roy, S; Shahripour, A; Sullivan, K; Swensen, AM; Tang, H; Teumelsan, N; Thomas-Fowlkes, B; Walsh, SP; Yang, L; Zhou, X; Zhu, Y1
DeWald, TA; Greene, SJ; Mentz, RJ; Peters, AE1
Bell, R; Bruce, S; Cooper, LB; deFilippi, C; Mentz, R; O'Connor, C; Psotka, M; Seliger, SL1
Anstrom, KJ; Eisenstein, EL; Greene, SJ; Harding, T; Harrington, A; Kim, DY; Mentz, RJ; Sachdev, V; Sapp, S; Velazquez, EJ1
Fukuda, K; Goda, A; Imaeda, S; Kohno, T; Kohsaka, S; Nagatomo, Y; Nakano, S; Niimi, N; Saji, M; Shiraishi, Y; Takei, M; Yoshikawa, T1
Menon, V; Verbrugge, FH1
Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harrington, AH; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Testani, JM; Velazquez, EJ1
DeWald, TA; Mentz, RJ; Velazquez, EJ1
Wolowich, WR1
Alexy, T; Ambrosy, AP; Anstrom, KJ; Clare, RM; Desvigne-Nickens, P; DeWald, TA; Eisenstein, EL; Greene, SJ; Ketema, F; Kim, DY; Mentz, RJ; Pitt, B; Psotka, MA; Rommel, JJ; Stevens, GR; Velazquez, EJ1
Kulkarni, NS1
Al-Habbaa, A; Eid, PS; Elkady, AH; Elsayed, GG; Elshafay, A; Hirayama, K; Huy, NT; Kien, ND; Minh, LHN; Mohammed, AT; Morra, ME; Nghia, TLB; Sherif, NA; Thanh, LV; Turk, T; Y, MN1
Bakuła, E; Balsam, P; Bednarski, J; Cacko, A; Filipiak, KJ; Fojt, A; Gawałko, M; Grabowski, M; Główczyńska, R; Kowalik, R; Marchel, M; Markulis, M; Niedziela, Ł; Niewiński, G; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Sieradzki, M; Tymińska, A1
Baduashvili, A1
Chan, JSK; Harky, A1
Badriddinova, L; Berechikidze, I; Kukes, V; Pavlova, L; Shikh, E; Tsvetkov, D1
Haeberle, M; Karle, CA1
Besche, B; Blondel, T; Garelli-Paar, C; Guillot, E; Oyama, MA1
Abouibrahim, MA; Do, VBD; Duy, LM; Eid, PS; Elfaituri, MK; Elrahman, MMA; Fahmy, MM; Hirayama, K; Huy, NT; Ibrahim, DA; Kandil, H; Minh, LHN; Shah, J; Shehata, MAA; Shinkar, A; Tam, DNH; Vuong, NL; Zayan, AH1
Alvarado, MP; Barbarino, A; Chetboul, V; Delle Cave, J; Depré, B; Ghazal, S; Lefort, S; Marchal, CR; Passavin, P; Poissonnier, C; Saponaro, V; Tissier, R; Trehiou-Sechi, E; Vannucci, E; Verwaerde, P1
Hu, J; Jiang, L; Li, M; Wan, Q; Yuan, F; Zhang, Y; Zhou, J1
Paulus, R; Schmidt, B1
Guo, Z; Li, L; Li, Y; Zhang, S1
Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harding, T; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Velazquez, EJ1
Bletskan, ММ; Ivano, NV; Korabelschykova, MO; Rоsul, ММ1
Blanc, J; Chetboul, V; Desquilbet, L; Lucats, L; Menard, J; Petit, A; Pouchelon, JL; Rougier, S; Woehrle, F1
Greene, SJ; Mentz, RJ1
Yao, Y; Zhang, J; Zhang, R; Zhang, Y1
Doshi, R; Mithawala, P; Patel, H; Shah, P1
Balsam, P; Crespo-Leiro, MG; Drożdż, J; Filipiak, KJ; Grabowski, M; Kapłon-Cieślicka, A; Kowalik, R; Maggioni, AP; Marchel, M; Opolski, G; Ozierański, K; Peller, M; Tymińska, A; Wancerz, A1
Anstrom, KJ; Eisenstein, EL; Gabriel, D; Greene, SJ; Harding, T; Harrington, A; Jones, I; Mentz, RJ; Prather, K; Velazquez, EJ1
Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Schellberg, D; Seiz, M; Täger, T1
Chen, M; Hanumanthu, BK; Kokkinidis, DG; Miles, JA; Patel, K; Siegel, RM1
Ahmed, D; Assi, AAR; Habra, M; Rahhal, A; Saad, MO; Tawengi, K1
Bikdeli, B; Coca, SG; Dharmarajan, K; Khan, U; Kim, N; Krumholz, HM; Li, SX; Partovian, C; Strait, KM; Testani, JM1
Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL1
Afanas'ev, SA; Nevdakh, AE; Repin, AN; Rogovskaia, IuB1
Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA1
Arutiunov, GP; Dragunov, DO; Sokolova, AV1
Kiiakbaev, GK; Kobalava, ZhD1
Ding, GL; Guo, SL; Han, LN; Lin, XM; Shi, XM; Yang, LM; Zang, CB1
Arutiunov, AG; Arutiunov, GP; Dragunov, DO; Rylova, AK; Sokolova, AV1
Anstrom, KJ; Buggey, J; Eisenstein, EL; Mentz, RJ; O'Connor, CM; Pitt, B; Velazquez, EJ1
Drożdż, J; Filipiak, KJ; Mamcarz, A; Nessler, J; Niemczyk, M; Tykarski, A; Wożakowska-Kapłon, B1
Frolkina, MO; Shiriaev, IV; Shtegman, OA1
Anstrom, KJ; Buggey, J; DeVore, AD; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, RJ; OʼConnor, CM; Schulte, PJ; Velazquez, EJ1
Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B1
Chiswell, K; Fiuzat, M; Givertz, MM; McKendry, C; Mentz, RJ; Metra, M; O'Connor, CM; Teerlink, JR; Velazquez, EJ; Voors, AA1
Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA1
Díez, J; Weber, KT1
Antony, S; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Watanabe, K1
Bakuła, E; Balsam, P; Cacko, A; Filipiak, KJ; Fojt, A; Grabowski, M; Główczyńska, R; Huczek, Z; Kowalik, R; Markulis, M; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Tymińska, A1
Baughman, KL; Desai, AS; Fang, JC; Givertz, MM; Lewis, EF; Mielniczuk, LM; Nohria, A; Stevenson, LW; Tsang, SW1
Ishido, H; Senzaki, H1
Beaumont, J; Díez, J; González, A; Larman, M; López, B; Querejeta, R2
Anguita, M; Castillo, JC; León, C; Toledano, F1
Nicklas, J; Pitt, B1
Cheng, XW; Harada, K; Hirashiki, A; Isobe, S; Izawa, H; Kobayashi, M; Murase, Y; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Yokota, M1
Aizawa, Y; Harima, M; Kodama, M; Tachikawa, H; Tanaka, H; Thanikachalam, PV; Watanabe, K; Yamaguchi, K1
Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E1
Corti, N; Elke, B; Locher, P; Wagner, CC1
Fromm, MF; Graf, B; Heinbüchner, S; Ince, H; Kische, S; König, J; Thürmann, P; Werner, D; Werner, U; Zolk, O1
Brooks, N; Clark, AL; Clayton, N; Gandhi, N; Gupta, S; Keevil, B; Neyses, L; Ng, LL; Waywell, C1
Davis, RC; MacFadyen, RJ; Ng Kam Chuen, MJ1
Acuña, C1
Arystanova, A; Khoseva, EN; Nekrasova, NI; Pataraia, SA; Preobrazhenskiĭ, DV; Talyzina, IV1
Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE1
Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ1
Cosín, J; Díez, J1
Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A1
Bigner, D; Craig, S; Wall, GC1
Akutagawa, O; Fukuda, M; Hayashi, T; Honda, K; Okamoto, M; Sasaki, T; Yamato, M1
Grajewska, M; Manitius, J; Sulikowska, B1
Gamba, G; Hess, B; Jaquet, F; Müller, K1
Díez, J; González, A; Larman, M; López, B; Querejeta, R; Sánchez, E1
Dohke, T; Fujii, M; Horie, M; Ishikawa, C; Ohno, K; Sakai, H; Takayama, T; Tsutamoto, T; Wada, A; Yamamoto, T1
Yamamoto, T; Yano, M1
Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T1
Eshaghian, S; Fonarow, GC; Horwich, TB1
Chuen, MJ; MacFadyen, RJ1
Batyraliev, TA; Marenich, AV; Preobrazhenskiĭ, DV; Sidorenko, BA; Tarykina, EV1
Caro-Vadillo, A; Montoya-Alonso, JA; Ynaraja-Ramírez, E1
Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K1
Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K1
Cantarovich, F; Hoste, E; Mehta, RL; Murray, P; Shaw, A1
Ishido, H; Kamiyama, M; Katogi, T; Kobayashi, T; Kyo, S; Masutani, S; Senzaki, H; Taketazu, M1
Dodion, L; Kesteloot, H; Stroobandt, R1
Brater, DC2
Adams, KF; Blose, JS; Patterson, JH1
Brogden, RN; Dunn, CJ; Fitton, A1
Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, DL1
Kramer, WG1
Ploch, T; Podszus, T; Wagner, U1
Casali, E; Castellani, ET; Mattioli, AV; Mattioli, G1
Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, D1
Bremner, S; Hariman, RJ; Jones, JP; Kostis, JB; Louie, EK; Nocero, MA; Rogers, WJ1
Leary, WP; Reyes, AJ1
Silke, B1
Reyes, AJ1
Fowler, SF; Murray, KM1
Black, PK; Brater, DC; Ferguson, J; Grant, AG; Kramer, WG; Serpas, T; Smith, WB1
Medert, G; Wittig, T1
Fisher, ML; Gottlieb, SS; Khatta, M; Kramer, WG; Roffman, D; Wentworth, D1
Bleske, BE; Kramer, WG; Nicklas, JM; Welage, LS1
Gorriz-Teruel, JL; Martínez-Mir, I; Pallardó-Mateu, LM; Palop-Larrea, V; Sancho-Calabuig, A1
Berman, BN; Bryant, J; Heaton, AH; Trotter, JP1
Andreini, I; Casini, A; Di Loreto, M; Liguori, A; Napoli, C1
Noe, LL; Pezzella, SM; Trotter, JP; Vreeland, MG1
Dreckmann-Behrendt, B; Goertz, A; Spannheimer, A1
Brater, DC; Forthofer, MM; Murray, MD; Stroupe, KT1
Plosker, GL; Young, M1
Kido, H; Ohtaki, Y1
Adams, LD; Bennett, SJ; Brater, DC; Deer, MM; Dexter, PR; Ferguson, JA; Lane, KA; Murray, MD; Perkins, SM; Smith, FE; Tierney, WM1
Cohn, JN1
Buckley, MM; Friedel, HA1
Achhammer, I; Glocke, M; Häcker, W1
Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC1

Reviews

29 review(s) available for torsemide and Cardiac Failure

ArticleYear
An evaluation of torsemide in patients with heart failure and renal disease.
    Expert review of cardiovascular therapy, 2022, Volume: 20, Issue:1

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Multicenter Studies as Topic; Sodium Potassium Chloride Symporter Inhibitors; Torsemide

2022
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
    Journal of evaluation in clinical practice, 2020, Volume: 26, Issue:3

    Topics: Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome

2020
[PHARMACOGENETIC ASPECTS OF TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE (REVIEW)].
    Georgian medical news, 2020, Issue:302

    Topics: Adrenergic beta-Antagonists; Diuretics; Heart Failure; Humans; Pharmacogenetics; Torsemide

2020
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.
    Heart failure reviews, 2021, Volume: 26, Issue:1

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide

2021
Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
    JACC. Heart failure, 2021, Volume: 9, Issue:5

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome

2021
Torsemide versus furosemide in heart failure patients: A meta-analysis of randomized controlled trials.
    European journal of internal medicine, 2018, Volume: 57

    Topics: Furosemide; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Time Factors; Torsemide; Treatment Outcome

2018
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2019, Volume: 20, Issue:6

    Topics: Furosemide; Heart Failure; Humans; Observational Studies as Topic; Patient Readmission; Randomized Controlled Trials as Topic; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome

2019
[Ways of optimizing diuretic therapy in congestive heart failure, chronic place torasemide prolonged release].
    Kardiologiia, 2014, Volume: 54, Issue:4

    Topics: Delayed-Action Preparations; Diuretics; Dose-Response Relationship, Drug; Drug Monitoring; Heart Failure; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2014
A reappraisal of loop diuretic choice in heart failure patients.
    American heart journal, 2015, Volume: 169, Issue:3

    Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, Physicians'; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Up-Regulation; Ventricular Dysfunction, Left

2015
Torasemide for the treatment of heart failure.
    Cardiovascular & hematological disorders drug targets, 2008, Volume: 8, Issue:2

    Topics: Animals; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Quality of Life; Sulfonamides; Torsemide

2008
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].
    Medicina clinica, 2008, Nov-15, Volume: 131, Issue:17

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Echocardiography, Doppler; Furosemide; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Meta-Analysis as Topic; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Torsemide

2008
[Frequent drug interactions in old age].
    Praxis, 2009, Oct-21, Volume: 98, Issue:21

    Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Depression; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Metoprolol; Paroxetine; Polypharmacy; Risk Factors; Sulfonamides; Torsemide

2009
[Update: prolonged-release torasemide].
    Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46 Suppl E

    Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide

2010
[Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].
    Kardiologiia, 2011, Volume: 51, Issue:4

    Topics: Biological Availability; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Half-Life; Heart Failure; Humans; Hyperglycemia; Hypertension; Hypokalemia; Loop of Henle; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Treatment Outcome

2011
Ethacrynic acid and the sulfa-sensitive patient.
    Archives of internal medicine, 2003, Jan-13, Volume: 163, Issue:1

    Topics: Aged; Diuretics; Drug Administration Schedule; Drug Hypersensitivity; Ethacrynic Acid; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Tubules; Male; Sulfonamides; Torsemide

2003
[Torasemide (Trifas) in clinical practice--own experience].
    Przeglad lekarski, 2003, Volume: 60, Issue:1

    Topics: Acute Kidney Injury; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Sulfonamides; Torsemide

2003
[Aldosterone antagonist therapy for chronic heart failure].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2

    Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Randomized Controlled Trials as Topic; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling

2005
[Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].
    Kardiologiia, 2006, Volume: 46, Issue:10

    Topics: Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2006
Pharmacokinetics and pharmacodynamics of torasemide in health and disease.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 3

    Topics: Diuretics; Heart Failure; Humans; Kidney Diseases; Sulfonamides; Torsemide

1993
Torsemide: a pyridine-sulfonylurea loop diuretic.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:4

    Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Renal Insufficiency; Sulfonamides; Torsemide

1995
Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Drugs, 1995, Volume: 49, Issue:1

    Topics: Age Factors; Animals; Clinical Trials as Topic; Diuretics; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Hypertension; Liver Cirrhosis; Renal Insufficiency; Sulfonamides; Torsemide

1995
Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
    Cardiology, 1994, Volume: 84 Suppl 2

    Topics: Diuretics; Heart Failure; Humans; Sulfonamides; Torsemide

1994
Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 1

    Topics: Calcium; Chlorides; Diuretics; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Natriuresis; Potassium; Sodium; Sulfonamides; Torsemide

1993
Central hemodynamic effects of diuretic therapy in chronic heart failure.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 1

    Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Muzolimine; Plasma Volume; Sulfonamides; Torsemide

1993
Diuretics in cardiovascular medicine: new wine into old bottles. Presentation of the fundamentals.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 1

    Topics: Diuretics; Electrolytes; Heart Failure; Humans; Hypertension; Natriuresis; Sulfonamides; Torsemide

1993
Torsemide: a new loop diuretic.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Aug-15, Volume: 52, Issue:16

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hypertension; Sulfonamides; Torsemide

1995
Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Drug safety, 1996, Volume: 14, Issue:2

    Topics: Antihypertensive Agents; Diuretics; Drug Interactions; Half-Life; Heart Failure; Hemodynamics; Humans; Hypertension; Sulfonamides; Torsemide

1996
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2001, Volume: 118, Issue:2

    Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Sulfonamides; Torsemide

2001
Torasemide. A review of its pharmacological properties and therapeutic potential.
    Drugs, 1991, Volume: 41, Issue:1

    Topics: Animals; Diuretics; Half-Life; Heart Failure; Hemodynamics; Humans; Hypertension; Kidney; Sulfonamides; Tissue Distribution; Torsemide

1991

Trials

42 trial(s) available for torsemide and Cardiac Failure

ArticleYear
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
    Journal of cardiac failure, 2022, Volume: 28, Issue:10

    Topics: Furosemide; Heart Failure; Humans; Reproducibility of Results; Torsemide; United States

2022
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    JAMA, 2023, 01-17, Volume: 329, Issue:3

    Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Discharge; Sodium Potassium Chloride Symporter Inhibitors; Torsemide; Treatment Outcome

2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Circulation, 2023, 07-11, Volume: 148, Issue:2

    Topics: Furosemide; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Torsemide

2023
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
    Cardiology journal, 2019, Volume: 26, Issue:6

    Topics: Aged; Comparative Effectiveness Research; Exercise Tolerance; Female; Furosemide; Heart Failure; Humans; Male; Pilot Projects; Poland; Preliminary Data; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome

2019
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
    Journal of veterinary internal medicine, 2020, Volume: 34, Issue:5

    Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; Torsemide

2020
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.
    BMC cardiovascular disorders, 2020, 10-14, Volume: 20, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss

2020
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol.
    Medicine, 2021, 02-19, Volume: 100, Issue:7

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide

2021
Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
    Journal of veterinary internal medicine, 2017, Volume: 31, Issue:6

    Topics: Animals; Diuretics; Dogs; Female; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome

2017
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
    European heart journal, 2014, May-14, Volume: 35, Issue:19

    Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines

2014
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue].
    Terapevticheskii arkhiv, 2014, Volume: 86, Issue:6

    Topics: Adult; Angiotensin II; Chronic Disease; Delayed-Action Preparations; Female; Half-Life; Heart Failure; Humans; Hypertension; Kidney Tubules; Male; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2014
[Effect of dosage forms loop diuretic with a different release rate for early and delayed the prognosis of patients with circulatory decompensation].
    Kardiologiia, 2014, Volume: 54, Issue:9

    Topics: Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Treatment Outcome; Water-Electrolyte Balance

2014
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Furosemide; Heart Failure; Humans; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Spain; Sulfonamides; Time Factors; Torsemide; Treatment Outcome; Urination

2015
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
    Future cardiology, 2015, Volume: 11, Issue:5

    Topics: Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Survival Rate; Time Factors; Torsemide; Treatment Outcome

2015
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    The American journal of cardiology, 2016, Feb-01, Volume: 117, Issue:3

    Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Furosemide; Global Health; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome

2016
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Trials, 2017, 01-23, Volume: 18, Issue:1

    Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; Furosemide; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Poland; Quality of Life; Recovery of Function; Research Design; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Surveys and Questionnaires; Time Factors; Torsemide; Treatment Outcome; Ventricular Remodeling; Walk Test

2017
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:2

    Topics: Aged; Collagen; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Prospective Studies; Protein-Lysine 6-Oxidase; Sulfonamides; Torsemide; Ultrasonography; Up-Regulation; Ventricular Dysfunction, Left

2009
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6

    Topics: Administration, Oral; Aldosterone; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Norepinephrine; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides; Sulfonamides; Sympathetic Nervous System; Systole; Torsemide; Ventricular Dysfunction, Left

2009
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
    Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:8

    Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Procollagen; Prospective Studies; Research Design; Sulfonamides; Torsemide

2009
Gender is an important determinant of the disposition of the loop diuretic torasemide.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:2

    Topics: Cell Line; Diuretics; Female; Heart Failure; Humans; Hypertension; Liver-Specific Organic Anion Transporter 1; Male; Mutagenesis, Site-Directed; Organic Anion Transporters; Polymorphism, Genetic; Sex Factors; Sulfonamides; Torsemide

2010
The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    European journal of heart failure, 2010, Volume: 12, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Intention to Treat Analysis; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prognosis; Quality of Life; Renin; Retrospective Studies; Sulfonamides; Systole; Torsemide; Ventricular Dysfunction, Left

2010
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    Clinical therapeutics, 2011, Volume: 33, Issue:9

    Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; Female; Fibrosis; Furosemide; Heart Failure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Procollagen; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome

2011
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2012, Volume: 14, Issue:1

    Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve Insufficiency; Sulfonamides; Torsemide

2012
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
    Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:5

    Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography, Doppler; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Regression Analysis; Sulfonamides; Torsemide; Ventricular Dysfunction, Left

2003
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
    European journal of heart failure, 2003, Volume: 5, Issue:6

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome

2003
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
    Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11

    Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Sulfonamides; Torsemide; Treatment Outcome

2004
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
    Journal of the American College of Cardiology, 2004, Dec-07, Volume: 44, Issue:11

    Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardium; Sulfonamides; Torsemide

2004
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:10

    Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Stroke Volume; Sulfonamides; Tomography, Emission-Computed, Single-Photon; Torsemide; Ventricular Remodeling

2006
Effect of torsemide on serum and urine electrolyte levels in dogs with congestive heart failure.
    The Veterinary record, 2007, Jun-16, Volume: 160, Issue:24

    Topics: Animals; Antihypertensive Agents; Dog Diseases; Dogs; Electrolytes; Heart Failure; Sulfonamides; Torsemide

2007
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Myocardium; Peptide Fragments; Pilot Projects; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Torsemide

2007
Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
    Archives internationales de pharmacodynamie et de therapie, 1982, Volume: 260, Issue:1

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide

1982
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biological Availability; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Sulfonamides; Torsemide

1995
Clinical and haemodynamic effects of long-term treatment with torasemide in congestive heart failure.
    Cardiology, 1994, Volume: 84 Suppl 2

    Topics: Diuretics; Exercise Test; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Sulfonamides; Torsemide

1994
Symptomatic achievements with diuretics in congestive heart failure.
    Cardiology, 1994, Volume: 84 Suppl 2

    Topics: Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Jugular Veins; Male; Middle Aged; Sulfonamides; Torsemide; Venous Pressure

1994
The pharmacodynamics of torsemide in patients with congestive heart failure.
    Clinical pharmacology and therapeutics, 1994, Volume: 56, Issue:1

    Topics: Administration, Oral; Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide

1994
Dose-response study of intravenous torsemide in congestive heart failure.
    American heart journal, 1994, Volume: 128, Issue:2

    Topics: Adult; Aged; Chlorides; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Potassium; Sodium; Sulfonamides; Torsemide; Urine

1994
Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:3

    Topics: Adult; Diuretics; Female; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Natriuresis; Sulfonamides; Torsemide

1996
Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:8

    Topics: Area Under Curve; Chromatography, High Pressure Liquid; Creatinine; Diuretics; Half-Life; Heart Failure; Hemodynamics; Humans; Sodium; Sulfonamides; Torsemide

1998
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Clinical therapeutics, 1999, Volume: 21, Issue:5

    Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Managed Care Programs; Quality of Life; Random Allocation; Sulfonamides; Surveys and Questionnaires; Torsemide

1999
Healthcare costs of patients with heart failure treated with torasemide or furosemide.
    PharmacoEconomics, 2000, Volume: 17, Issue:5

    Topics: Adult; Aged; Diuretics; Drug Costs; Female; Furosemide; Health Care Costs; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide

2000
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
    The American journal of medicine, 2001, Volume: 111, Issue:7

    Topics: Aged; Biological Availability; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome

2001
Efficacy and safety of torasemide in patients with chronic heart failure.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:1A

    Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pulse; Random Allocation; Sulfonamides; Torsemide; Water-Electrolyte Balance

1988
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
    European journal of clinical pharmacology, 1986, Volume: 31 Suppl

    Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Osmolar Concentration; Phosphates; Random Allocation; Sulfonamides; Torsemide; Urine

1986

Other Studies

61 other study(ies) available for torsemide and Cardiac Failure

ArticleYear
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
    Bioorganic & medicinal chemistry letters, 2016, 12-01, Volume: 26, Issue:23

    Topics: Animals; Diuresis; Dogs; Heart Failure; Humans; Hypertension; Macaca mulatta; Oxazines; Potassium Channels, Inwardly Rectifying; Rats, Sprague-Dawley; Transcriptional Regulator ERG

2016
Proteomic differences among patients with heart failure taking furosemide or torsemide.
    Clinical cardiology, 2022, Volume: 45, Issue:3

    Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Proteomics; Torsemide

2022
Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    ESC heart failure, 2022, Volume: 9, Issue:5

    Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Sodium Potassium Chloride Symporter Inhibitors; Torsemide

2022
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial.
    European heart journal. Acute cardiovascular care, 2022, 12-27, Volume: 11, Issue:12

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Torsemide; Treatment Outcome

2022
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
    JAMA, 2023, 05-16, Volume: 329, Issue:19

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide

2023
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure.
    JAMA, 2023, 05-16, Volume: 329, Issue:19

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide

2023
No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart Failure.
    American family physician, 2023, Volume: 108, Issue:1

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide

2023
Simpson's Paradox: Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
    The American journal of cardiology, 2020, 04-15, Volume: 125, Issue:8

    Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Torsemide

2020
Simpson's Paradox in Meta-Analysis - Choice of Studies and Summary Statistics.
    The American journal of cardiology, 2020, 07-15, Volume: 127

    Topics: Data Interpretation, Statistical; Furosemide; Heart Failure; Humans; Torsemide

2020
Photodermatitis caused by torasemide.
    Contact dermatitis, 2021, Volume: 84, Issue:1

    Topics: Aged; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrochlorothiazide; Lymphedema; Molecular Structure; Photosensitivity Disorders; Torsemide

2021
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
    BMC veterinary research, 2020, Sep-16, Volume: 16, Issue:1

    Topics: Animals; Cat Diseases; Cats; Diuretics; Female; Furosemide; Heart Failure; Male; Retrospective Studies; Torsemide; Treatment Outcome

2020
90-year-old man • dyspnea • lower extremity edema • limitations in daily activities • Dx?
    The Journal of family practice, 2020, Volume: 69, Issue:9

    Topics: Activities of Daily Living; Aged, 80 and over; Diagnosis, Differential; Diuretics; Dyspnea; Edema; Female; Heart Failure; Humans; Lisinopril; Lower Extremity; Metoprolol; Obesity; Spironolactone; Torsemide

2020
LOOP DIURETICS IN HEART FAILURE: EVIDENCE-BASED CHOICE.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2021, Volume: 74, Issue:4

    Topics: Diuretics; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2021
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
    European journal of heart failure, 2018, Volume: 20, Issue:3

    Topics: Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water

2018
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
    International heart journal, 2018, Jul-31, Volume: 59, Issue:4

    Topics: Aged; China; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Proportional Hazards Models; Sulfonamides; Torsemide

2018
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Cardiovascular drugs and therapy, 2019, Volume: 33, Issue:1

    Topics: Aged; Disease Progression; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Poland; Recovery of Function; Registries; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome

2019
Death: The Simple Clinical Trial Endpoint.
    Studies in health technology and informatics, 2019, Volume: 257

    Topics: Clinical Trials as Topic; Data Collection; Diuretics; Endpoint Determination; Furosemide; Heart Failure; Humans; Mortality; Torsemide

2019
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    International journal of cardiology, 2019, 08-15, Volume: 289

    Topics: Aged; Blood Pressure; Bumetanide; Cause of Death; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left

2019
Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    BMC cardiovascular disorders, 2019, 05-28, Volume: 19, Issue:1

    Topics: Aged; Drug Substitution; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Patient Readmission; Qatar; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome

2019
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
    Journal of the American College of Cardiology, 2013, Apr-09, Volume: 61, Issue:14

    Topics: Databases, Factual; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Survival Analysis; Torsemide; Treatment Outcome

2013
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
    International journal of clinical practice, 2013, Volume: 67, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ventricular Dysfunction, Left; Young Adult

2013
[Influence of the long-term administration of torasemide on morphometric characteristics of cardiac muscle under conditions of developed experimental postinfarction cardiosclerosis].
    Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:9

    Topics: Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Endocardium; Endomyocardial Fibrosis; Heart Failure; Histocytochemistry; Myocardium; Rats; Rats, Wistar; Sulfonamides; Torsemide; Treatment Failure

2013
Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
    Genetics and molecular research : GMR, 2014, Sep-05, Volume: 13, Issue:3

    Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disease Progression; Diuretics; Echocardiography, Doppler, Color; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Incidence; Male; Middle Aged; Prognosis; Sulfonamides; Torsemide; Treatment Outcome

2014
[Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
    Kardiologia polska, 2015, Volume: 73, Issue:3

    Topics: Cardiology; Furosemide; Heart Failure; Humans; Poland; Societies, Medical; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2015
[Test with torasemide in the differential diagnosis of dyspnea in patients with cardiovascular diseases].
    Kardiologiia, 2014, Volume: 54, Issue:11

    Topics: Adult; Aged; Chronic Disease; Diagnosis, Differential; Diuretics; Dyspnea; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Torsemide

2014
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
    Journal of cardiovascular pharmacology, 2015, Volume: 65, Issue:5

    Topics: Academic Medical Centers; Aged; Comorbidity; Databases, Factual; Female; Furosemide; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; North Carolina; Retrospective Studies; Risk Factors; Sex Factors; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Tertiary Care Centers; Torsemide; Treatment Outcome; Ultrasonography

2015
Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
    Circulation. Heart failure, 2016, Volume: 9, Issue:8

    Topics: Animals; Cardiovascular Agents; Clinical Decision-Making; Fibrosis; Heart Failure; Humans; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Patient Selection; Precision Medicine; Proteins; Sulfonamides; Torsemide; Ventricular Remodeling

2016
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
    BioFactors (Oxford, England), 2017, Volume: 43, Issue:2

    Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models, Animal; Furosemide; Gene Expression Regulation; Heart Failure; Humans; Rats; Sulfonamides; Swine; Torsemide

2017
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
    Journal of cardiac failure, 2008, Volume: 14, Issue:5

    Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diuretics; Female; Furosemide; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome

2008
Loop diuretics in patients with heart failure: time to change to torsemide?
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2009
[Effects of various diuretics on cardiac function in rats with heart failure].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:7

    Topics: Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Diuretics; Furosemide; Heart Failure; Hemodynamics; Male; Myocardium; Rats; Rats, Inbred Lew; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling

2009
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
    European journal of heart failure, 2010, Volume: 12, Issue:7

    Topics: Biomarkers; Diuretics; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Sulfonamides; Systole; Torsemide; Ventricular Dysfunction, Left

2010
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2011, Volume: 13, Issue:4

    Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart Failure; Male; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide

2011
Torasemide in chronic heart failure: results of the TORIC study.
    European journal of heart failure, 2002, Volume: 4, Issue:4

    Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Product Surveillance, Postmarketing; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left

2002
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Praxis, 2002, Sep-11, Volume: 91, Issue:37

    Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Germany; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Retrospective Studies; Sulfonamides; Switzerland; Torsemide

2002
[A better diuretic for patients with heart failure. Better control of potassium loss].
    MMW Fortschritte der Medizin, 2002, Aug-08, Volume: 144, Issue:31-32

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Sulfonamides; Torsemide; Treatment Outcome

2002
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
    MMW Fortschritte der Medizin, 2002, Oct-03, Volume: 144, Issue:40

    Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Torsemide

2002
[Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
    MMW Fortschritte der Medizin, 2003, Jan-23, Volume: 145, Issue:3-4

    Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Furosemide; Heart Failure; Hospital Costs; Humans; Length of Stay; Sulfonamides; Torsemide

2003
[Hear failure. Indications for diuretic therapy in general practice].
    MMW Fortschritte der Medizin, 2003, May-01, Volume: 145, Issue:18

    Topics: Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water-Electrolyte Balance

2003
[Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].
    MMW Fortschritte der Medizin, 2003, Jun-05, Volume: 145, Issue:23

    Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Myocardial Contraction; Prognosis; Sulfonamides; Torsemide; Treatment Outcome

2003
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
    MMW Fortschritte der Medizin, 2003, Aug-07, Volume: 145, Issue:31-32

    Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Prognosis; Sulfonamides; Time Factors; Torsemide

2003
[Heart failure therapy. Cheap can become expensive].
    MMW Fortschritte der Medizin, 2003, Oct-09, Volume: 145, Issue:41

    Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Drug Costs; Furosemide; Germany; Heart Failure; Humans; Patient Readmission; Sulfonamides; Survival Analysis; Torsemide

2003
Relation of loop diuretic dose to mortality in advanced heart failure.
    The American journal of cardiology, 2006, Jun-15, Volume: 97, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide

2006
Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
    The American journal of cardiology, 2006, Nov-15, Volume: 98, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide; Ventricular Dysfunction, Left

2006
Comparative effects of torasemide and furosemide in rats with heart failure.
    Biochemical pharmacology, 2008, Feb-01, Volume: 75, Issue:3

    Topics: Animals; Collagen Type III; Cytochrome P-450 CYP11B2; Diuretics; Furosemide; Heart Failure; Immunohistochemistry; Male; Myocardium; Rats; Rats, Inbred Lew; Sulfonamides; Survival Rate; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left

2008
Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
    European journal of pharmacology, 2008, Feb-26, Volume: 581, Issue:1-2

    Topics: Animals; Atrial Natriuretic Factor; Body Weight; Cardiomyopathy, Dilated; Collagen Type III; Disease Progression; Diuretics; Heart Failure; Male; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; RNA, Messenger; Sulfonamides; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left

2008
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
    The International journal of artificial organs, 2008, Volume: 31, Issue:2

    Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepatorenal Syndrome; Humans; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Natriuretic Agents; Nephrotic Syndrome; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ultrafiltration; Water-Electrolyte Imbalance

2008
Efficacy and safety of torasemide in children with heart failure.
    Archives of disease in childhood, 2008, Volume: 93, Issue:9

    Topics: Child, Preschool; Chronic Disease; Diuretics; Female; Heart Failure; Humans; Infant; Infant, Newborn; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Prospective Studies; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome

2008
Torsemide (Demadex)--a new loop diuretic.
    The Medical letter on drugs and therapeutics, 1994, Aug-19, Volume: 36, Issue:929

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Edema; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Liver Diseases; Sulfonamides; Torsemide

1994
[Torasemide in patients with chronic heart failure. Results of clinical administration in general practice].
    Fortschritte der Medizin, 1996, Jan-30, Volume: 114, Issue:3

    Topics: Adult; Aged; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide

1996
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
    The American journal of medicine, 1998, Volume: 104, Issue:6

    Topics: Aged; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Severity of Illness Index; Sulfonamides; Torsemide

1998
Vasculitis with acute kidney failure and torasemide.
    Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144

    Topics: Aged; Antihypertensive Agents; Diuretics; Heart Failure; Humans; Male; Renal Insufficiency; Sulfonamides; Torsemide; Vasculitis, Leukocytoclastic, Cutaneous

1998
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
    Medical interface, 1996, Volume: 9, Issue:1

    Topics: Aged; Cost Control; Diuretics; Drug Costs; Drug Utilization Review; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Male; Managed Care Programs; Middle Aged; Patient Compliance; Sulfonamides; Torsemide

1996
Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
    European journal of clinical pharmacology, 1999, Volume: 55, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Diuretics; Endothelium, Vascular; Epithelium; Epoprostenol; Female; Furosemide; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Kidney; Male; Middle Aged; Sulfonamides; Thromboxane B2; Torsemide; Vasodilator Agents

1999
Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
    International journal of clinical practice, 1998, Volume: 52, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cross-Sectional Studies; Diuretics; Economics, Pharmaceutical; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides; Torsemide

1998
[Decreased mortality. Help for the failing heart].
    MMW Fortschritte der Medizin, 2000, Aug-24, Volume: 142, Issue:33-34

    Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome

2000
[Pharmaco-economics of heart failure. The proper diuretic helps reduce costs].
    MMW Fortschritte der Medizin, 2000, Nov-30, Volume: 142, Issue:48

    Topics: Cost Savings; Diuretics; Drug Costs; Germany; Heart Failure; Humans; Patient Readmission; Sulfonamides; Torsemide

2000
Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
    PharmacoEconomics, 2001, Volume: 19, Issue:6

    Topics: Chronic Disease; Clinical Trials as Topic; Costs and Cost Analysis; Heart Failure; Humans; Sulfonamides; Torsemide

2001
Optimal diuretic therapy for heart failure.
    The American journal of medicine, 2001, Volume: 111, Issue:7

    Topics: Biological Availability; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide

2001
[Diuretics in heart failure. Can they also prolong life?].
    MMW Fortschritte der Medizin, 2001, Dec-06, Volume: 143, Issue:49-50

    Topics: Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide

2001
[Which diuretic in heart failure? For the prognosis, they are not all equal].
    MMW Fortschritte der Medizin, 2002, Mar-28, Volume: 144, Issue:13

    Topics: Clinical Trials as Topic; Diuretics; Edema, Cardiac; Heart Failure; Humans; Prognosis; Sulfonamides; Torsemide; Treatment Outcome

2002